These 3 Stocks Are Crushing the "Magnificent Seven" This Year -- Are They Still Buys?The Motley Fool • 10/12/26
10x Genomics & Fred Hutch Join Forces on Cancer Biomarker ResearchZacks Investment Research • 10/08/26
10x Genomics Announces New Collaboration to Advance Single Cell and Spatial Applications Across Solid Tumors and Blood CancersPRNewsWire • 10/07/26
10x Genomics Begins Atera Shipments as Spatial Biology Demand RisesZacks Investment Research • 09/30/26
10x Genomics Announces Sentira, a New Computational Platform to Turn Complex Biological Data Into Experimental ConclusionsPRNewsWire • 09/29/26
10x Genomics Begins Global Shipments of Atera, Putting Unprecedented Spatial Biology Capabilities in Researchers' HandsPRNewsWire • 09/29/26
Lunit Announces Collaboration with 10x Genomics to Integrate AI-Enabled Pathology Analysis with Spatial Molecular Data for Oncology Clinical ResearchPRNewsWire • 09/10/26
10x Genomics Rallies 84% in 3 Months: Is There More Upside Ahead?Zacks Investment Research • 09/03/26
TXG Stock Down Despite Patent Verdict Win Against Parse BiosciencesZacks Investment Research • 08/31/26
10x Genomics: The Turnaround Is Real, But Atera Now Has To Deliver (Rating Upgrade)Seeking Alpha • 08/20/26
10x Genomics Q2 Earnings & Revenues Beat Estimates, Gross Margin UpZacks Investment Research • 08/07/26
10x Genomics (TXG) Q2 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 08/06/26
10x Genomics (TXG) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Zacks Investment Research • 07/30/26
10x Genomics and Lausanne University Hospital Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies for Cancer CarePRNewsWire • 07/29/26